Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Apimeds Pharmaceuticals US Inc. (APUS : AMX)

Sector: Healthcare

Close
(12-05-2025)
$2.14
Change
-$0.12 (-5.31%)
Volume 31,664
Open $2.19
Day Range $2.06 - $2.26
52 Week Low $1.37
52 Week High $4.03
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $26,912,604
Shares Outstanding 12,575,983
Book Value per Share $3.29
Earnings per Share -$0.18
Period
Loading...
Loading...

Legend

Apimeds Pharmaceuticals US Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
December 05, 2025 2.14
-$0.12 (-5.31%)
December 04, 2025 2.26
$0.08 (3.67%)
December 03, 2025 2.18
-$0.02 (-0.91%)
December 02, 2025 2.20
-$0.09 (-3.93%)
December 01, 2025 2.29
-$0.61 (-21.03%)
November 28, 2025 2.90
$0.71 (32.42%)
November 27, 2025 2.19
$0.00 (0.00%)
November 26, 2025 2.19
$0.24 (12.31%)
November 25, 2025 1.95
-$0.08 (-3.94%)
November 24, 2025 2.03
-$0.25 (-10.96%)
November 21, 2025 2.28
-$0.12 (-5.00%)
November 20, 2025 2.40
-$0.63 (-20.79%)
November 19, 2025 3.03
-$0.05 (-1.62%)
November 18, 2025 3.08
-$0.82 (-20.92%)
November 17, 2025 3.90
$0.69 (21.34%)
November 14, 2025 3.21
$0.42 (15.05%)
November 13, 2025 2.79
$0.11 (4.10%)
November 12, 2025 2.68
$0.01 (0.37%)
November 11, 2025 2.67
-$0.02 (-0.60%)
November 10, 2025 2.69
$0.46 (20.45%)
November 07, 2025 2.23
-$0.28 (-11.30%)
November 06, 2025 2.51
-$0.23 (-8.25%)
November 05, 2025 2.74
$0.00 (0.00%)
November 04, 2025 2.74
$0.26 (10.48%)
November 03, 2025 2.48
$0.29 (13.24%)
October 31, 2025 2.19
$0.15 (7.35%)
October 30, 2025 2.04
$0.01 (0.49%)
October 29, 2025 2.03
-$0.01 (-0.29%)
October 28, 2025 2.04
$0.11 (5.49%)
October 27, 2025 1.93
-$0.05 (-2.53%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports